Background: The management of chronic pain is complex and often involves the integration of multiple clinical, humanistic, and economic factors. Primary care physicians (PCPs) are often at the forefront of managing chronic pain and often initiate pharmacological pain management therapy. To date little is known surrounding the pain management practices of PCPs.
Pain Physician:November/December 2018: 21:E593-E602 E594 www.painphysicianjournal.com knowledge of PCPs regarding the therapeutics of pain medication, assessment and patient monitoring practices, within the framework of both evidence-based medicine and professional association guidelines for chronic pain treatment.
Methods

Study Design
The cross-sectional questionnaire survey evaluated PCPs pain management treatment practices including adherence to evidence-based chronic pain management guidelines, level of patient monitoring, knowledge, educational sources, and patient challenges and barriers for appropriate chronic pain treatments. The study was approved by the University Institutional Review Board.
Instrument Description
The questionnaire was developed based on an extensive review of the literature including published professional association guidelines. The survey included close ended, fixed choice questions assessing physician knowledge and practice. Prior to administration, the questionnaire was tested for content validity and clarity by a pain specialist and was pilot tested on a limited number of PCPs (n = 5). The survey instrument is included in Appendix A.
Survey Administration
Following pilot testing, the questionnaire was mailed in the summer of 2015 to a convenience sample (n = 300) of PCPs practicing in Western Pennsylvania. The survey responses were evaluated for knowledge determination and compliance with evidence-based guidelines. When possible, the evidence-based knowledge questions were categorized as true or false responses if peer-reviewed references provided welldefined knowledge information. When conflicting or inconclusive evidence existed for a specific question, the question was classified as conflicting or inconclusive evidence. In addition, the opioid prescribing survey responses were compared to the 12 opioid prescribing recommendations detailed in the CDC Guideline for Prescribing Opioids for Chronic Pain to evaluate practice compliance prior to publication in 2016. In order to discuss the results, a threshold of greater than or equal to 75% adherence rate to evidence-based research was chosen for the evidence-based knowledge questions. P rimary care physicians (PCPs) are often at the forefront of pain treatment for the estimated 100 million Americans suffering from chronic pain. A 2003 survey conducted to gauge the perception of pain sufferers reported that most pain sufferers (63%) had seen their family doctor for help (1). Furthermore, a large percentage of a PCPs' practice will involve some management of chronic pain since the prevalence of chronic pain is more than the combined incidences of diabetes, heart disease, and cancer in the United States (US) (2) .
The knowledge base of a PCP is critical to guiding appropriate pain management care. The management of chronic pain is complex and involves the integration of multiple clinical, humanistic, and economic factors (1). Primary care physicians are often involved in the initiation of pain management therapy, especially pharmacologic therapy. Appropriate treatment of chronic pain involves accurate patient assessment, adherence to evidence-based treatment guidelines, appropriate patient monitoring, and specialized physician knowledge of treatment interventions.
In the US, opioid prescriptions by PCPs has been increasing since 2007 without corresponding evidence for their widespread use for chronic noncancer pain (2) . Recognizing the importance of PCPs in the management of pain and the opioid epidemic, the Center for Disease Control and Prevention (CDC) in March of 2016 issued PCP opioid prescribing guidelines (2) (3) (4) (5) . Some of the key action statements in the guidelines include: 1) preference for non-opioid medication for chronic pain treatment; 2) risks and benefits should be considered before opioids; 3) treatment goals for opioid therapy should be established; 4) consider lowest possible dose and consider risks when increasing to 50 morphine milligram equivalents or more per day; 5) avoid multiple opioids or benzodiazepines with opioids; 6) continued assessment at a minimum of every 3 months and review drug monitoring data for high risk patients; and 7) provide treatment options for patient with opioid use disorder.
Given the important role PCPs play in the management of chronic pain, it is surprising to note that the assessment, prescribing and monitoring of chronic pain patients in a primary care setting has not been extensively studied raising concerns regarding appropriate treatment. The aim of this study is to assess the knowledge and practice of PCPs in treating chronic pain patients. Specifically, the research will assess the www.painphysicianjournal.com
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Statistical Analysis
Descriptive statistics were utilized for patient demographic and practice characteristics such as assessment and monitoring practices with categorical variables represented with n (%) and continuous variables reported as mean and standard deviation (SD). The respondents were asked to rank 6 sources of information in order: published literature, pharmaceutical drug representatives, expert opinion, medical liaisons, clinical experience and academic detailers. All statistical analysis was conducted using Statistical Package for Social Sciences version 22.0 (SPSS Inc., Armonk, NY: IBM Corp.).
Results
A total of 48 useable responses were received for a response rate of 16%. Table 1 summarizes physician demographic and practice characteristics. The majority of the sample was comprised of middle-aged, male physicians with an average of 19 years in practice, primarily practicing in suburban settings treating an average of 20 chronic pain patients a week. In descending order osteoarthritis, back, and neuropathic pain were the most common pain states treated. Only 67% of respondents referred to pain management guidelines. The major source of educational information was published literature (58.3%) with clinical experience as the second highest rated source (31.3%). Educational information from drug representatives (2.1%), medical liasons (4.2%), and academic detailers (4.2%) accounted for the least referenced educational sources. Table 2 presents assessment practices for chronic pain. Approximately 50% of surveyed PCPs used pain assessment scales for chronic pain and continued their utilization at time of follow-up. For opioid pain management, greater than 68% of surveyed PCPs did not utilize opioid risk assessment tools either prior to initiation or at follow-up for opioid therapy. Table 3 presents PCPs perceived importance of procedures/activities before initiating chronic pain therapy. Assessing physical history and discussing the risks and benefits of treatment were rated as highly important by 100% of the sample. Assessing psychiatric and medical comorbidities, medication history, identifying barriers, and discussing non-pharmacological treatment were rated as extremely important by over 90% of the sample. Furthermore, assessing pain duration, utilizing a written contract and categorizing pain based upon biological mechanism was extremely important to the majority of the sample. Using a pain rating scale for every visit was rated as low importance by slightly over half of the sample. Table 4 reports the frequency of challenges that PCPs face in treating patients with chronic pain. The two most prevalent challenges cited were resistance to non-pharmacological treatment (mean = 4.23, SD = 0.92) and unrealistic treatment expectations (Mean = 4.17, SD = 0.86). Poor adherence and cultural beliefs were perceived as less frequent challenges. Chemical Table 5 . Patient factors including medical and substance abuse history as well as drug effectiveness, safety, cost, and drug interactions were all viewed as extremely important. Interestingly, patient preferences and socioeconomic status were rated as less important.
PCPs' knowledge on 5 main classes of medications (antidepressants, anticonvulsants, opioids, and acetaminophen and nonsteroidal anti-inflammatory drugs and topical agents) utilized for chronic pain were assessed (Table 6 ) . The first set of questions assessed the knowledge of evidence for antidepressant use. The respondents scored 75% or better adherence rate on 4 of the 12 conclusive evidence questions. Of particular note was that 29.2% and 16.6%, respectively, either cited no evidence or were not sure regarding the safe use of TCAs with cardiac patients. The requirement for ECGs for patients above 40 years of age was cited as no evidence or not sure by 25% and 29.1% of the respondents, respectively.
For the anticonvulsants questions, only 1 out of 8 had an adherence rate of greater than 75%. Approximately 37.6% of the respondents believed that it is safe to stop anti-epileptics which is not consistent with the available evidence recommending tapering because withdrawal symptoms can develop in addition to exacerbation of psychotic symptoms in vulnerable populations. Pregabalin can be associated with suicidal thoughts and depression and still 71.9% of the respondents either were not sure or cited no evidence. Also, the respondents did not meet the 75% adherence level for evidence regarding anticonvulsants use for nociceptive pain, caution for use for gabapentin and pregabalin in renal insufficiency and the use of gabapentin for lower back pain.
Regarding opiate prescribing, this study was conducted before the publication of the CDC guidelines (2-5). However, 3 of the survey questions paralleled the CDC guidelines. Regarding the use of opioids as first line therapy for chronic pain, while the CDC guidelines do not recommend opiates as a first line treatment, the respondents were divided based on the available evidence. Also, 90% of the respondents preferred long-acting opioids over short-acting while the CDC guidelines recommend the opposite. Finally, the CDC guidelines recommend against opioid doses exceeding 90 MME per day, but the respondents were split between no evidence or not sure with only 22.9% citing evidence for the guideline recommendation. Although the evidence is inconclusive or conflicting, the effectiveness of random drug screens compared to routine screens were endorsed by 91.7% of the respondents. A total of 89.7% of PCPS stated there was evidence demonstrating preference for the use of extended release opioids over immediate release and 39.6% stated that there was evidence of reduced respiratory depression when opioids are used for chronic pain management in comparison to acute pain management. For the 2 questions, which seem to have equivocal evidence [fixed interval versus PRN dosing (6), neonatal risk in pregnant women (7), driving safely on opioid prescriptions (8)] greater than 50% of the respondents stated that there was evidence for these practices.
Finally, for NSAIDS, acetaminophen, and topical agents, the 75% threshold for adherence to evidence was not achieved by the respondents regarding the following questions: acetaminophen as a better agent for first line therapy in lower back pain; capsaicin cream as first line therapy in HIV neuropathy; and lidocaine patch as an effective first line therapy for postherpetic neuralgia. Additional analyses was conducted comparing private practice physicians with all other categories primarily focusing on the opioid knowledge questions that parallel the CDC guidelines and drug information sources. There were no statistical differences observed between the groups on these selected parameters. discussion Primary care physicians are often at the forefront of chronic pain management. The survey results here provide significant insight into PCP practices and highlight areas for future educational efforts that are needed to enhance pain management. First, educational efforts to enhance PCP understanding of evidence-based guidelines, pharmacological management, opioid compliance monitoring, and pain assessment of chronic pain are needed. In addition, the survey highlights the need for patient education on the realities of chronic pain management and the importance of nonpharmacological treatment.
Our data indicate that PCPs have significant insight into the importance of knowledge acquisition surrounding patients' physical and mental status including medical and psychiatric comorbidities including substance abuse prior to the initiation of chronic pain therapy. Greater than 90% of the surveyed physicians considered assessing physical history, psychiatric co-E598 morbidities, medical comorbidities, and medication history highly important prior to the initiation of therapy. These practices are reassuring since managing chronic pain is complex and includes multiple variable assessments during the decision process. A recent claims data analysis examining pain management in 4 cohorts of patients demonstrated that chronic pain patients have on average 4 or more prescribing physicians and greater than 50 prescription claim counts over a 2-year period (9) . Both of these data points further reinforce the importance of the measures taken by PCPs in the survey prior to the initiation of chronic pain therapy. In addition to the importance of assessing medical and psychiatric comorbidities, the PCPs in the survey also understood the importance of gathering patient history before initiating chronic pain therapy. When selecting pharmacotherapeutic treatment options for chronic pain management, the PCPs survey listed drug effectiveness, drug safety, drug cost, and ease of drug administration as highly important. Both medication regimen and cost have been shown to influence compliance with therapy in multiple disease states. When regimen complexity and burden is reduced, compliance with therapy increases (10) . Furthermore, when cost-sharing increases adherence to medication management protocols decreases (11) . Therefore, cost assessment, including patient financial responsibility, should be factored in decision-making when selecting pharmacotherapeutic agents for the treatment of chronic pain.
One area of assessment that would benefit from additional education is the importance of pain assessment. Among the PCPs surveyed in the study, less than 50% of the respondents viewed the use of pain assessment scales in follow-up care as important. Additionally, less than 50% of responding PCPs thought that using a pain rating scale at each follow-up visit was of high importance. The assessment of pain is a critical step in providing high-quality pain management. A lack of appropriate pain assessment has been shown to negatively influence the quality of pain care (12) . Therefore, additional education is warranted on appropriate pain assessment tools and in encouraging PCPs to regularly assess pain control at follow-up care.
Significant evidence gaps were identified in the use of nonopioid pharmacotherapeutics for pain manDue to missing data, some statements have less than 48 responses.
www.painphysicianjournal.com agement. A large number of physicians in the survey treated conditions that often utilize non-opioid forms of pain control as the first line of treatment. Approximately 90% of the patients treated by the PCPs had neuropathic pain and 99% had osteoarthritic pain. Both of these conditions utilize non-opioid pharmacotherapeutic treatment options for pain management. Evidence gaps were identified in the use of non-opioid medications commonly used for the treatment of neuropathic pain including antidepressants and anticonvulsants (13) .
Evidence-based guidelines have been published for the pharmacological management of neuropathic pain which have defined first line, second line, and third line medications (13, 14) . These recommendations not only assess efficacy but also provide insight on side-effects and appropriate prescribing. Unfortunately, a majority (67%) of responding physicians did not seem to refer to guidelines for therapy. This suggests that when pain management guidelines are published, educational efforts should not only be made to chronic pain physicians but also the PCPs.
Based on the survey responses regarding opioid therapy, additional education is warranted. Primary care physicians represent the largest group of opioid prescribers in the US (15) . The CDC published opioid guidelines in 2016 based on the significant role that PCPs play in the management of chronic pain and in prescribing opioids (4, 5) . Although the survey occurred prior to the guidelines and the associated 12 recommendations for opioid therapy, it provides insight into PCP practices and reaffirms the recommendations made by the CDC guidelines. Multiple areas surrounding opioid therapy requiring further education were highlighted in the survey including the use of opioids as first-line treatments and opioid risk assessment tools prior to the initiation of therapy, safe dose limits, extended release opioids, impact of opioids on the endocrine and respiratory systems, and the influence of opioids on driving ability. In addition, continued reinforcement of important practice patterns already being highly considered by PCPs including assessment of substance abuse and discussing the risks and benefits of chronic pain treatment should continue.
Based on the survey results, further patient education is needed on chronic pain management treatment, the realities of treatment, and the goals of treatment. The management of chronic pain is often challenging and treatment results may be limited, with complete pain relief often not achievable. Challenges highlighted in the survey included unrealistic treatment expectations and resistance to nonpharmacological treatments. Our data is in agreement with previous data demonstrating the discrepancy between patients and physicians on management goals for chronic pain treatment (16) . The patient level of health literacy was also highlighted. Additional patient education may further help increase patients' knowledge levels and align patients and PCPs on chronic pain management goals.
As with any survey, limitations exist. First, the response rate was 16%. Although low, this response rate is comparable to response rates of 14% and 13% for other chronic pain management topics including anticoagulation and prescription patterns for chronic pain physicians (17, 18) . In addition, greater than 50% of the respondents were from private practice; therefore, the results may not pertain to other practice settings including academic and hospital-based practices. Even though the survey has limitations, it still provides significant insight into PCP pain management practices in the community setting for a group of physicians with an average of approximately 20 years in clinical practice that treat on average greater than 30 individuals dealing with chronic pain per month. In addition, the responding physicians treated a wide variety of pain states including neuropathic, nociceptive, osteoarthritis, radicular, fibromyalgia, and back and cancer pain. The survey is representative of the primary care practice setting where the predominance of care is provided to patients in the US, the community, and outpatient setting.
conclusion
In conclusion, this study provides insight into PCPs' chronic pain management practices and highlights areas required for further education. Additionally, the survey defines the importance of increasing patients' knowledge of chronic pain treatment. When guidelines are published, educational efforts should be placed on informing not only pain management physicians but also PCPs. PCPs are often at the forefront of pain management treatment and enhancement in knowledge will ultimately influence pain management outcomes and treatment.
Appendix 1 is available online at: https://asippfiles.sharefile.com/d-sf9150fc78404f2e9
